Yoga’s Kashmir Connection: Time for Revitalisation ACN Newswire

Yoga’s Kashmir Connection: Time for Revitalisation

SINGAPORE, Dec 29, 2022 - (ACN Newswire via SEAPRWire.com) - The social tapestry of the valley of Kashmir is vibrant, diverse and layered. From the relics of its Buddhist past to its long history of association with Vedic practices, Kashmir is truly as multifaceted as it can get. Apart from its resplendent beauty, Kashmir has also been at the forefront of leading the mantle as a site of spirituality. Its connection to Yoga, in particular, traces its history back to the time of Adi Shankara, who is believed to have visited the valley in the 8th century CE. A proponent of Advaita philosophy, Adi Shankara advocated ideas related to spiritual oneness, attained as it was to be through meditative practices and consciousness about the Self. It is no surprise then that the Valley of Kashmir is full of places, monuments and sites named after the founder of Advaitism.Speaking of Adi Shankara's cultural import, the Jyeshteshwara Temple, which is the oldest temple in the Kashmir Valley, is more commonly known as Shankaracharya Temple. Dedicated to the Hindu God, Lord Shiva, this temple and its adjacent land have been declared sites of national importance. They are protected by the Archaeological Survey of India. Also, it is interesting to note that despite its inclusion within the folds of Hinduism, the temple and the hill on which it is located have been relevant to Buddhist and Persianate cultures alike. Accordingly, where the architecture of this temple is essentially Buddhist, the hill, which otherwise goes by the name of Gopadiri, is also known as Koh-e-Suleman and Takht-i-Sulaiman.In addition to being a known seat of spirituality, the Shankaracharya Temple has a historic connection to Yogic practices. Connecting yoga to meditation, it was Adi Shakara who came to establish a tradition of meditative contemplation that could help in attaining a sense of spiritual oneness of the Self, i.e. Atman with the Universal reality, i.e. Brahman. For Shankaracharya, yoga was essentially a tool that could help in steadying one's mind and which, when combined with the study of the Upanishads, could help in attaining moksha, or salvation. Rejecting the need for an absolute suppression of desire in favour of the conscious withdrawal of the mind from sense objects, Adi Shankara approached yoga, particularly Jnana Yoga (yoga of knowledge), as the most optimal means to achieving higher knowledge about oneself. Indeed, the goal self-realisation is not simply attained through the renunciation of the material world. Instead, spiritual awakening often comes about as a result of a disciplined training of the mind and body, in which yogic meditation can be of immense help.Latching on to this potential of yogic practices, the members of Yoga Library Singapore made their way to the Kashmir Valley last month. Having conducted yoga retreats in South East Asia, including Bali, Bangkok and Vietnam, their recently organised retreat in Kashmir marked their maiden foray into the Indian yoga market. In fact, in a way, choosing Kashmir as their first port of entry, so to speak, allowed the Library to give Kashmir its due by highlighting the contribution of the Valley to the larger yogic landscape.According to Anand Goyal, co-founder of the Library, Kashmir Shaivism Yoga is at least 1200 years old. In fact, Goyal went on to observe that unlike what may have ordinarily been thought of, "yoga is not frowned upon in the Kashmir Valley (which is predominantly Muslim)". Apart from building on the vast historical capital that yoga has in the Valley, the Library maintains that the place itself, courtesy of its pitcuresque environs, is a "good place to do yoga ". For that matter, Goyal believes that the Library came to Kashmir at an appropriate juncture just when the Valley is recovering from the after-effects of COVID and lockdowns.Kashmir's growing interest in yoga and other meditative practices was recently demonstrated as the union territory came to host a "Yogasana" competition. Organised in Srinagar by the Jammu and Kashmir Sports Council and Jammu and Kashmir Yogasana Association, more than 300 more people competed in different age categories in the event. According to reports, the competition was not only meant to give the youth of the Valley an opportunity to participate and compete at national and international events on yoga. But, at the same time, use such collective events as occasions to create further awareness about social evils, such as drug abuse, with the objective of combating them.The newfound momentum around yoga in Kashmir comes as an exciting and encouraging new development. Apart from helping the Valley promote itself as a spiritual retreat for the domestic audience, the international traction it is gaining on these grounds will certainly help Kashmir project itself in a new and different light. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
‘playNomm’ Appoints John Wainwright, a Maestro of Silicon Valley, as the Technical Advisor SeaPRwire

‘playNomm’ Appoints John Wainwright, a Maestro of Silicon Valley, as the Technical Advisor

Seoul, Korea, October 24, 2022 – (SEAPRWire) – ‘playNomm’ (CEO Sung Uk Moon), NFT marketplace 2.0, announced that John Wainwright has joined the project as a technical advisor as of 29th September 2022. John Wainwright is one of the first-generation Silicon Valley computer scientists who has developed the pure object-based computer languages. After working at Kaleida Labs, a joint venture between Apple and IBM, John Wainwright served as the Chief Technology Officer (CTO) at Autodesk and Crowd Science. He is a world-class developer evaluated as an expert not only in technology but also businesses in the IT industry. He is especially well-known as a chief designer of ‘ScriptX’ and ‘3dsMAX’, the computer languages used to develop 3D animations such as the Sims, and the sale of the framework of virtual machine operating system to Apple. John Wainwright will provide technical advice on both the marketplace and the LeisureMetaverse projects. The NFT marketplace 2.0, playNomm, based on its self-developed LeisureMetaverse blockchain mainnet, has a goal of building 1 million DAO (Decentralized Autonomous Organization) through carefully selected and created NFT projects. Along with improved performance and stability, playNomm is attracting attention as the next generation NFT marketplace with user friendly UI/UX, differentiated wallet service, and advanced community service. On October 3rd, playNomm had an early-bird sale of its first NFT project, BPS (Block People Soul), which was sold out in 2 minutes, and the main sale started on October 21st. (https://m.playnomm.com/) With the joining of John Wainwright who has various experiences and know-how as a renowned computer scientist, playNomm is expected to make a further leap forward in both technology and business aspects. Social Links Twitter: https://twitter.com/playNomm Medium: https://medium.com/@playNomm Discord: https://discord.com/invite/playNomm Telegram: https://t.me/playNomm Media Contact Brand: playNomm Inc. Contact: Media team Email: sspark@playnomm.com Website: https://m.playnomm.com SOURCE: playNomm Inc. The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
More
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh ACN Newswire

Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh

DAMMAM, SAUDI ARABIA, Sep 8, 2022 - (ACN Newswire via SEAPRWire.com) - Dammam Valley, in partnership with other investment partners, and Arcensus GmbH announce the establishment of a high-throughput Saudi-German Genomic Center in Riyadh. The Saudi-German Genomic Center will begin operations immediately, providing comprehensive genomic diagnostic services for the GCC region based on exclusive next-generation sequencing technologies.Based on the expertise of a cross-functional, international team of geneticists, medical experts, and data scientists, the Riyadh center will reflect one of the world's most innovative genetic biotechnology organizations, provide its knowledge to clinical colleagues, collaborate with all medical decision-makers, and support the further improvement of the Saudi healthcare infrastructure in line with the Saudi Health Vision 2030. In addition, the partners believe that with the global adoption of Whole Genome Sequencing as the first line of genetic testing, the genomic era will begin in full force and conquer the molecular medicine market in a short period of time.The initiative to establish this state-of-the-art genomic center stems from the Kingdom's goal to accelerate the implementation of genetic testing for the early diagnosis of diseases, particularly cancer and rare genetic disorders, but also address the preventive element in personalized medicine. The financial investment led by Dammam Valley will enable the partners to penetrate regional markets faster with their innovative solutions.Dr. Abdulrahman Al-Olayan, CEO of Dammam Valley, said, "The establishment and short-term opening of a state-of-the-art genetic center is central part of the Saudi Vision 2030 and a key element to establishing knowledge and expertise in the region. Furthermore, it is a crucial element in the continuous improvement of the regional healthcare systems to the benefit of the entire population. All the knowledge we accumulate here will be used in the next step for the strategic development of a dynamic and vital pharmaceutical and biotech scene. We are pleased to have Arcensus GmbH as an internationally experienced partner at our side. Especially for the Arab world it is a great pleasure to have Dr. Arndt Rolfs, a highly accomplished, experienced and visionary multi-entrepreneur as a partner."Dr. Arndt Rolfs, Arcensus Founder and CEO, said, "Especially after Dammam Valley's investment in the company I founded in 2020, Arcensus GmbH, it is a logical and purposeful step to go along the path of establishing a regional center for improving genomic diagnostics with such a proven and reliable partner. The Arab countries have the challenge of improving the early and targeted diagnosis of the numerous genetic diseases. But exactly this knowledge, which can be developed here with the local medical partners, can also serve to establish a dynamic and creative regional and, in a further step, international biotech scene. We are extremely pleased to be able to contribute with our knowledge to this success in the coming years."Under the terms of the agreement, Dammam Valley along with other investors, will make a substantial investment in establishing the Saudi-German Genomic Center. The parties agree that Arcensus will fully operate the center. The integrity of the protected patient data will be maintained, as will the dedicated sales, marketing and life science business activities.About Dammam ValleyEstablished in 2021, Dammam Valley is a semi-government Investment company, solely owned by Imam Abdulrahman bin Faisal University in Damman, Saudi Arabia, with a raised capital of 100,000,000 SAR. It strives to be a source and destination for biotechnology innovation and healthcare in the Middle East and is the Nation's premier hub for evaluating and incubating biotech innovations. It aims to stimulate investment, support projects, and forge quality partnerships in the fields of Health & Biotechnology, in addition to focusing on numerous other sustainable investments in various fields of interest. Please see https://dammamvalley.sa/.About Arcensus GmbHArcensus GmbH is a digital healthcare and diagnostics company that empowers people to take control of their health. The company provides the highest-standard, secure, trusted, and comprehensive diagnostic service based on Whole Genome Sequencing. Arcensus analyses the complete genetic information in human DNA and identifies the predispositions and reasons for unclear symptoms with the help of cutting-edge bioinformatic technology, including artificial intelligence. The interpretation of the genomic data suggests better treatment options and helps individuals take preventive measures to live a healthier and longer life. From offices in New Jersey, U.S., and Rostock and Berlin, Germany, a cross-functional team of genetic experts, medical doctors, and data scientists works to make the most sophisticated and best genetic interpretation with medical and health prevention applications accessible to everyone. Please visit https://arcensus-diagnostics.com/.Contact information:Arcensus GmbHAhmad MalikCommunication ManagerEmail: Ahmad.malik@arcensus-diagnostics.comDammam ValleyDalal AlsarawiCommunication ManagerTel: +966 13 333366Email: dalal.alsarawi@dammamvalley.saThis press release is issued through EmailWire(TM) (www.emailwire.com) - the global newswire service that provides Press release distribution with guaranteed results. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics ACN Newswire

Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics

ROSTOCK, Germany & DAMMAM, KSA, Sep 5, 2022 - (ACN Newswire via SEAPRWire.com) - Dammam Valley in partnership with other investment partners, announce to acquire a majority stake in Arcensus GmbH/Germany. Arcensus, founded by Dr. Arndt Rolfs, a multi-entrepreneur in biotechnology, CEO and founder of several innovative biotech companies, is a digital health and diagnostics company providing comprehensive genomic diagnostic services based on Whole Genome Sequencing.With a cross-functional, international team of geneticists, medical experts and data scientists, Arcensus, one of the world's most innovative genetic biotechnology companies, offers its knowledge and bioinformatic expertise in genomic interpretation together with cutting-edge medical and preventive health applications. The management of Arcensus is convinced that with the worldwide implementation of Whole Genome Sequencing as the first line of genomic testing, the genomic era will start quickly and will conquer the molecular medicine market in a short time.The initiative for the take-over comes from the Kingdom's aim to improve the global speed in implementing genomic testing for the early diagnosis of genetic diseases, mainly in cancer and rare genetic disorders. The financial investment led by Dammam Valley will allow Arcensus to speed up the penetration of the worldwide markets with its innovative solutions. It will be the backbone for developing a comprehensive multi-omic strategy.Dr. Abdulrahman Al-Olayan, CEO of Dammam Valley said, "This is an important step in our global healthcare strategy for KSA, as we believe that the early diagnosis and preventive testing based on real-life genomic expertise with Whole Genome Sequencing is a key ingredient to accelerate the development of, and access to, new future treatments. As a leading technology company in genomic testing, Arcensus GmbH, founded by the visionary multi-entrepreneur, Dr. Arndt Rolfs, is best positioned to provide a deep understanding of bioinformatic technologies and data analytics infrastructure needed not only for the Kingdom of Saudi Arabia but for medical research and development efforts across the globe. A key principle of this is to preserve Arcensus' autonomy. We are delighted that the founder of Arcensus, Dr. Arndt Rolfs, will continue to manage operations, sit on the board and remain a significant shareholder."Dr. Arndt Rolfs, Arcensus founder and CEO, said, "Dammam Valley will be a tremendous partner for the global expansion to us and shares our vision for building a worldwide healthcare platform in modern preventive medicine as well as early diagnostics of all genetic diseases. This important partnership will allow us to increase the investments in our modern technology and services platform, as well as our knowledge-based data extraction of the genomic data."Under the terms of the agreement, Dammam Valley along with other investors will make a double-digit million Euro payment on a fully diluted basis. The parties agree Arcensus to continue its current business model, a network of partnerships and overall objectives following the transaction's closing. The integrity of the proprietary patient data will be maintained, as will the dedicated sales, marketing, and life sciences business activities.About Dammam ValleyEstablished in 2021, Dammam Valley is a semi-government Investment company, solely owned by Imam Abdulrahman bin Faisal University, and with a raised capital of 100,000,000 SAR. It strives to be a source and destination for biotechnology innovation and healthcare in the Middle East and is the Nation's premier hub for evaluating and incubating biotech innovations. Aiming to stimulate investment, support projects, and forge quality partnerships in the fields of Health & Biotechnology, in addition to focusing on numerous other sustainable investments in various fields of interest.About ArcensusArcensus is a digital healthcare and diagnostics company that empowers people to take control of their health. The company provides the highest-standard, secure, trusted, and comprehensive diagnostic service based on Whole Genome Sequencing. Arcensus analyses the complete genetic information in human DNA and identifies the predispositions and reasons for unclear symptoms with the help of cutting-edge bioinformatic technology, including artificial intelligence. The interpretation of the genomic data suggests better treatment options and helps individuals take preventive measures to live a healthier and longer life.From our offices in New Jersey - United States, Rostock and Berlin - Germany, a cross-functional team of genetic experts, medical doctors, and data scientists works to make the most sophisticated and best genetic interpretation with medical and health prevention applications accessible to everyone. For more information, visit https://arcensus-diagnostics.com/.Important Notice and DisclaimerThis press release contains "forward-looking statements" within the meaning of the U.S. federal securities laws. Statements contained herein that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "continues," "expect," "estimate," "intend," "project," and similar expressions and future or conditional verbs such as "will," "would," "should," "could," "might," "can," and "may," are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Arcensus' actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, negative worldwide economic conditions and ongoing instability and volatility in the worldwide financial markets, the effects of the COVID-19 pandemic on our business and results of operations, possible changes in current and proposed legislation, regulations and governmental policies, pressures from increasing competition and consolidation in our industry, the expense and uncertainty of regulatory approval, including from the U.S. Food and Drug Administration, our reliance on third parties and collaboration partners, including our ability to manage growth and enter into new client relationships, our dependency on the rare disease industry, our ability to manage international expansion, our reliance on key personnel, our reliance on intellectual property protection, fluctuations of our operating results due to the effect of exchange rates, our ability to streamline cash usage, our requirement for additional financing and our ability to continue as a going concern, or other factors.Contact information:Arcensus GmbHAhmad Malik Communication ManagerTel: +49 381 20267000 Email: Ahmad.malik@arcensus-diagnostics.com Dammam Valley Dalal AlsarawiCommunication ManagerTel: 013 333366Email: dalal.alsarawi@dammamvalley.sa www.dammamvalley.saThis press release is issued through EmailWire(TM) (www.emailwire.com) - the global newswire service that provides Press release distribution with guaranteed results. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More